----
Current ValuationThe current P/E ratio is -6.30, below the reasonable range, cheaper than 90.42% of the time in the past 1 years, and the industry ranks 7/9, the industry Median 23.90.
-6.3xP/E
$64.99Stock price
$-10.32Earnings per share
-6.3xP/E
Stock price$64.99Earnings per share$-10.32
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- -4.09x
- Typical range
- -5.27x–-2.99x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 23.90x
010203040
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 23.90x
0x10x20x30x40x50x
| Name/Symbol | |||
|---|---|---|---|
CNCUSCentene | -6.30x | 128.36% | $32.10B |
MOHUSMolina Healthcare | -1,452.80x | 64.17% | $10.17B |
CLOVUSClover Health Investments | -131.91x | 133.21% | $2.42B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
